Pacific Biosciences Of California PACB
NASDAQ PACB
$1.96 +0.12 (+6.52%)
At close: Oct 20, 2026 · 4:00 PM EDT

Pacific Biosciences Of California (PACB) EV to CFO (2020)

Updated

Pacific Biosciences Of California's (PACB) EV to CFO was 239.41 for Q4 2020, up 138.1% from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) EV to CFO (2020) Analysis & Trends

Dating back to Q1 2020, Pacific Biosciences Of California's EV to CFO record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q4 2020 came in at 100.57 (Q3 2020), 25.56 (Q2 2020) and 14.69 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Pacific Biosciences Of California 613.54 Mn -477.45 Mn 12.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 239.41
Sep 30, 2020 100.57
Jun 30, 2020 25.56
Mar 31, 2020 14.69
API Access

Pacific Biosciences Of California EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PACB&period=max&api_key=YOUR_API_KEY